Online citations, reference lists, and bibliographies.
← Back to Search

Effects Of Absorption Enhancers On Rat Nasal Epithelium In Vivo: Release Of Marker Compounds In The Nasal Cavity

E. Marttin, J. Verhoef, S. Romeijn, F. H. H. M. Merkus
Published 2004 · Chemistry, Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
AbstractPurpose. The assessment of the effects of nasal absorption enhancers on the rat nasal epithelium and membrane permeability in vivo after a single nasal dose of the enhancers. Methods. The release of marker compounds (protein, cholesterol and acid phosphatase) from the nasal epithelium was measured using a lavage technique. The nasal membrane permeability was determined after intravenous administration of a systemic tracer (FITC-albumin). Results. The effects of the absorption enhancers could be classified into four categories. The first consisted of HPβCD (5%), DMβCD (2%) and RAMEB (2%) and was not different from the control (physiological saline). For the second category, DMβCD (5%), effects were significantly higher than for the control. The third category, SGC (1%), was more active than DMβCD (5%) but less active than the last group. The fourth, most membrane damaging, category consisted of STDHF (1%), laureth-9 (1%) and LPC (1%). Administration of these three enhancers also resulted in release of acid phosphatase, indicating that severe membrane damage occurred. The release of cholesterol from nasal epithelium was largely dependent on the cholesterol solubilisation of the absorption enhancers. The amount of cholesterol released by laureth-9 and LPC was the largest. Conclusions. The results of this in vivo study are in agreement (i.e. similarity in rank order) with morphological and ciliotoxicity studies of nasal absorption enhancers, demonstrating that this invivo model is a valuable tool to classify nasal absorption enhancers according to their effects on the rat nasal epithelium.
This paper references
10.1023/A:1015808023310
Nasal Membrane and Intracellular Protein and Enzyme Release by Bile Salts and Bile Salt-Fatty Acid Mixed Micelles: Correlation with Facilitated Drug Transport
Z. Shao (2004)
10.1016/0168-3659(92)90019-N
Absorption enhancers in nasal insulin delivery and their influence on nasal ciliary functioning
N. Schipper (1992)
10.1016/0169-409X(93)90015-V
The relevance of nasal physiology to the design of drug absorption studies
S. Gizurarson (1993)
10.1023/A:1015896405389
Absorption Enhancing Effect of Cyclodextrins on Intranasally Administered Insulin in Rats
F. H. H. M. Merkus (2004)
10.1016/0378-5173(91)90344-N
Nasal absorption in rats. II. Effect of enhancers on insulin absorption and nasal histology
Susan G. Chandler (1991)
10.1023/A:1015904730599
The Molecular Weight Dependence of Nasal Absorption: The Effect of Absorption Enhancers
M. Donovan (2004)
10.1023/A:1018927710280
Tolerability and Absorption Enhancement of Intranasally Administered Octreotide by Sodium Taurodihydrofusidate in Healthy Subjects
T. Kissel (2004)
10.1016/0378-5173(94)00238-Z
Effects of formulation variables on nasal epithelial cell integrity: Biochemical evaluations
Chetan P. Pujara (1995)
10.1016/0928-0987(94)90017-5
Cyclodextrins as protection agents against enhancer damage in nasal delivery systems II. Effect on in vivo absorption of insulin and histopathology of nasal membrane
I. Gill (1994)
Nasal mucosal permeability after methacholine, substance P, and capsaicin challenge in the rat.
G. Petersson (1990)
10.1016/0168-3659(93)90179-9
Absorption enhancers in nasal drug delivery: efficacy and safety
F. W. H. M. Merkus (1993)
10.1002/AJA.1001790103
Enzyme histochemistry of the rat nasal mucosa embedded in cold glycol methacrylate.
H. W. Randall (1987)
10.1023/A:1016463118748
The Influence of Drugs on Nasal Ciliary Movement
W. Hermens (2004)
10.1023/A:1015847604654
Cyclodextrins as Nasal Absorption Promoters of Insulin: Mechanistic Evaluations
Z. Shao (2004)
Protein measurement with the Folin phenol reagent.
O. H. Lowry (1951)
10.1248/CPB.40.1252
Effect of cyclodextrins on biological membrane. II. Mechanism of enhancement on the intestinal absorption of non-absorbable drug by cyclodextrins.
K. Nakanishi (1992)
10.1177/000348948008900415
Characteristics of Capillary Permeability in Nasal Mucosa
K. Watanabe (1980)
10.1016/0378-5173(92)90053-5
Enhancing effects of cyclodextrins on nasal absorption of insulin in rats
T. Irie (1992)
10.1016/0378-5173(81)90058-2
Absorption of drugs from the nasal mucosa of rat
Hirai Shinichiro (1981)
10.1023/A:1015856430657
The Effects of Permeation Enhancers on the Surface Morphology of the Rat Nasal Mucosa: A Scanning Electron Microscopy Study
R. D. Ennis (2004)



This paper is referenced by
10.1007/s40199-019-00281-4
Intranasal Zotepine Nanosuspension: intended for improved brain distribution in rats
Sravanthi Reddy Pailla (2019)
10.1016/S0378-5173(02)00345-9
The effects of water-soluble cyclodextrins on the histological integrity of the rat nasal mucosa.
K. Asai (2002)
10.1016/j.jconrel.2009.03.019
Aerosolized liposomes with dipalmitoyl phosphatidylcholine enhance pulmonary insulin delivery.
S. Chono (2009)
10.1248/BPB.28.510
Effect of aminated gelatin on the nasal absorption of insulin in rats.
T. Seki (2005)
10.1016/J.IJPHARM.2007.02.004
Effects of a sperminated gelatin on the nasal absorption of insulin.
T. Seki (2007)
20 Nasal Delivery of Peptide Drugs
D. Pillion (2006)
10.1023/A:1014801714590
Gastropods as an Evaluation Tool for Screening the Irritating Potency of Absorption Enhancers and Drugs
E. Adriaens (2004)
10.1016/J.IJPHARM.2006.07.038
Rapid-onset intranasal delivery of metoclopramide hydrochloride Part II: Safety of various absorption enhancers and pharmacokinetic evaluation.
N. M. Zaki (2006)
10.1016/J.IJPHARM.2006.07.040
Rapid-onset intranasal delivery of metoclopramide hydrochloride. Part I. Influence of formulation variables on drug absorption in anesthetized rats.
N. M. Zaki (2006)
10.1016/S0378-5173(03)00090-5
Enhancing effect of chitosan on nasal absorption of salmon calcitonin in rats: comparison with hydroxypropyl- and dimethyl-beta-cyclodextrins.
Prapasri Sinswat (2003)
10.1248/bpb.b18-00673
Enhancement Effect of Poly-L-ornithine on the Nasal Absorption of Water-Soluble Macromolecules in Rats.
Shigehiro Omori (2019)
10.1023/A:1012109329631
Confocal Laser Scanning Microscopic Visualization of the Transport of Dextrans After Nasal Administration to Rats: Effects of Absorption Enhancers
E. Marttin (2004)
Novel Delivery Systems for Nasal Adminstration of Anthrax Vaccine
S. H. Wang (2010)
10.1023/A:1012136608249
Cyclodextrins: Their Future in Drug Formulation and Delivery
V. Stella (2004)
10.1016/j.jconrel.2013.06.010
On employing a translationally controlled tumor protein-derived protein transduction domain analog for transmucosal delivery of drugs.
Hae-duck Bae (2013)
10.1016/S0168-3659(02)00128-1
Analysis of transient and reversible effects of poly-L-arginine on the in vivo nasal absorption of FITC-dextran in rats.
Kazuo Ohtake (2002)
10.1517/17425247.2011.607437
Nasal route: an alternative approach for antiemetic drug delivery
Y. Ozsoy (2011)
10.18452/14962
Einfluss von Formulierungsparametern auf die nasale Verfügbarkeit von Natriumcromoglicat, Xylometazolinhydrochlorid und Oxymetazolinhydrochlorid
Sigrun Krase (2003)
10.1248/YAKUSHI.131.307
[Effects of sperminated pullulans on the pulmonary absorption of insulin].
T. Seki (2011)
10.1016/j.ijpharm.2019.118635
Strategies to facilitate or block nose-to-brain drug delivery.
P. Martins (2019)
10.1124/JPET.301.1.391
Intranasal delivery of morphine.
L. Illum (2002)
Optimisation and validation of an alternative mucosal irritation test
M. M. M. Dhondt (2005)
10.1080/03639045.2017.1353521
Aerosolized liposomes with dipalmitoyl phosphatidylcholine enhance pulmonary absorption of encapsulated insulin compared with co-administered insulin
S. Chono (2017)
10.1007/82_2011_167
Dry powder vaccines for mucosal administration: critical factors in manufacture and delivery.
S. H. Wang (2012)
10.1016/J.EJPS.2007.08.006
Enhanced bioavailability of metoclopramide HCl by intranasal administration of a mucoadhesive in situ gel with modulated rheological and mucociliary transport properties.
N. M. Zaki (2007)
10.1016/S1773-2247(13)50086-4
Nasal Drug Delivery of a Mucoadhesive Oxybutynin Chloride Gel: In Vitro Evaluation and In Vivo in Situ Study in Experimental Rats
S. El-Gizawy (2013)
10.1021/bp050208u
Role of Caco‐2 Cell Monolayers in Prediction of Intestinal Drug Absorption
Pranav J. Shah (2006)
10.1211/0022357022377
Alkanoylsucroses in nasal delivery of low molecular weight heparins: in‐vivo absorption and reversibility studies in rats
T. Yang (2004)
10.1016/S0168-3659(01)00540-5
The enhancing effect of nasal absorption of FITC-dextran 4,400 by β-sitosterol β-d-glucoside in rabbits
Kouji Nakamura (2002)
10.1006/TAAP.2002.9444
Evaluation of an alternative mucosal irritation test using slugs.
E. Adriaens (2002)
10.3109/1061186X.2012.693499
Strategies for non-invasive delivery of biologics
S. J. Chung (2012)
10.1016/J.JDDST.2017.09.021
Brain targeted rivastigmine mucoadhesive thermosensitive In situ gel: Optimization, in vitro evaluation, radiolabeling, in vivo pharmacokinetics and biodistribution
Dalia M N Abouhussein (2018)
See more
Semantic Scholar Logo Some data provided by SemanticScholar